Biocracked
Approach: the human outcome. Palette: C, natural.

A low-angle, side-on close shot of a sprinter's lower legs and spiked shoes at the start of a worn terracotta-red running track, just after sunrise. Low golden daylight rakes across the lane lines and picks out the sweat on the calf muscles and the tendons in the ankle. Behind the athlete, soft-focus green grass and a line of trees fill the background. The runner's face is out of frame. A single electric-green shoelace on one spiked shoe is the only accent. The depth of field is shallow, with the foreground track grain crisp and the background creamy. The mood is quiet and determined, with natural skin tones, earthy reds, and fresh greens. No blue cast, no text, no logos.
Peptides

শীর্ষ ক্রীড়াবিদদের শরীরে MOTS‑c ৫৯% বেশি, কোনো ইনজেকশন ছাড়াই

Helix Ward · · 5 min read

Before you buy a vial of the "exercise mimetic" peptide, consider this: a small new study found that elite sprinters and field athletes already carry about 59% more circulating MOTS-c than sedentary young men, and nobody gave them an injection.

The finding comes from a cross‑sectional study in Antioxidants (Zhang et al., 2026) from Tianjin University of Sport. It is a small snapshot of 30 people, not a trial. It still adds a useful data point to a peptide that is often marketed as a shortcut to what training already does.

What is MOTS-c?

MOTS-c is a short peptide encoded in mitochondrial DNA rather than the nuclear genome. It belongs to the "mitochondrial‑derived peptides," which are described as signaling molecules, or mitokines. The authors call it an exercise‑responsive mitokine, meaning its levels appear to shift with physical activity. Its link to metabolism and exercise is why it has picked up the "exercise mimetic" label in online peptide circles.

The paper's own framing is more modest. The authors say the associations between MOTS-c, exercise capacity and antioxidant markers "remain unclear," and that is the gap they set out to address.

The three groups

The researchers recruited 30 healthy males aged 18 to 25 and split them into three groups of 10:

  • Elite track and field athletes
  • Recreationally active individuals
  • Sedentary controls

They measured serum MOTS-c alongside superoxide dismutase (SOD, an antioxidant enzyme) and post‑exercise malondialdehyde (MDA, a common marker of oxidative damage to lipids). They also ran a battery of fitness tests: VO2max, forced vital capacity, vertical jump, handgrip strength, back muscle endurance and post‑fatigue back muscle force.

The numbers

MOTS-c rose step by step with fitness level:

Group Serum MOTS-c (pg/mL)
Elite athletes 507.51 ± 67.42
Recreationally active 440.32 ± 32.83
Sedentary 319.31 ± 99.07

The difference was statistically significant (p < 0.001). The athlete‑versus‑sedentary comparison had a Hedges' g of 2.13, a very large effect size. The "59%" figure is simply the athlete average divided by the sedentary average. The active group sat in the middle, roughly 38% above sedentary by the same arithmetic.

What tracked with MOTS-c

Across the whole sample, MOTS-c correlated strongly with several measures (all p < 0.001):

  • Absolute VO2max: r = 0.892
  • SOD: r = 0.847
  • Post‑exercise MDA: r = −0.910, so higher MOTS-c went with less oxidative damage after exercise
  • Back muscle endurance: r = 0.725
  • Post‑fatigue back muscle force: r = 0.812

Handgrip strength was the exception. It showed no significant correlation (r = 0.315, p = 0.090). The pattern points more toward endurance and fatigue‑related capacity than raw grip strength, though with this sample size that is a tentative reading.

In an exploratory hierarchical regression, post‑exercise MDA stayed significantly associated with MOTS-c after adjusting for VO2max. SOD did not. So the link between MOTS-c and lower oxidative damage may not be explained by aerobic fitness alone, but the authors label this analysis exploratory.

Limits you need to know

This is where the headline needs to be read carefully.

  • Cross‑sectional design. Everyone was measured once. The authors state plainly that the design "precludes causal inference." We cannot say training raised MOTS-c, that high MOTS-c made people fitter, or that something else (genetics, diet, training history) drives both.
  • Tiny sample. Ten people per group, all young males. The findings say nothing definitive about women, older adults or people with metabolic disease.
  • Wide spread in the sedentary group. Its standard deviation (about 99 pg/mL) is large, so individual values overlap and group averages hide a lot.
  • Circulating levels only. The study measured natural serum MOTS‑c. It tested no injected peptide, no doses and no timing.
  • Correlation is not mechanism. Strong r values in 30 people can be inflated by comparing extreme groups such as elite athletes and sedentary controls.

Takeaways

1. Training is associated with higher MOTS‑c in your own body. The most defensible reading is that fitter people in this sample had higher endogenous MOTS‑c. If MOTS‑c is part of how exercise benefits the body, you may already be producing more of it by training. This study cannot prove that, but it fits the "exercise‑responsive" description.

2. This study gives no basis for dosing or timing. The paper has no dosing, injection schedule or intervention data. Any dose or timing protocol you see online cannot be drawn from this work. Anyone wanting to know whether injected MOTS‑c does anything in humans needs controlled trials, which this is not. Animal and lab studies on the peptide are preclinical background and shouldn't be assumed to carry over to people.

3. Who is this for? Based on the evidence here, nobody in particular. The study is descriptive and does not identify a group that should use the peptide. Higher natural levels in athletes do not show that raising levels artificially would give non‑athletes the same benefits. Athletes' MOTS‑c was embedded in a whole physiology shaped by years of training.

4. Regulatory context (not from the paper). The study says nothing about legal status. To my knowledge MOTS‑c is not an approved medicine, but check current regulatory status yourself. Competitive athletes should not assume it is permitted and should check the current WADA Prohibited List or ask their anti‑doping organization before using any research peptide. I cannot confirm from the source how it is currently listed.

5. The practical bottom line. Aerobic fitness showed the clearest relationship with MOTS‑c here, and VO2max is something you can train. Regular exercise is a well‑established way to improve it, with no injection required.

The bigger picture

The study fits a growing view that mitochondria send signals that coordinate whole‑body metabolism, and that exercise changes those signals. What it cannot do is show that adding the signal from outside reproduces the effect of the training behind it. The most useful next steps would be longitudinal studies that track MOTS‑c as people begin training, and randomized trials in larger and more diverse groups. Until then, the 59% figure is better read as a measure of how different athletes' biology is than as a case for supplementation.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: the human outcome. Palette: warm, golden-hour light.

A woman in her fifties seen from behind and slightly above, in a low lunge on a yoga mat. Her face is out of frame, and only her shoulders, outstretched arms and tied-back silver-brown hair show. She practices on a wooden floor beside a tall window as low amber sunlight rakes across the room. The light picks out the weave of her rust-colored top and the fine skin texture of her forearms. In the foreground, a small glass dish of deep red-orange astaxanthin softgels sits slightly out of focus on the floor, catching a copper glow. A single small electric green water bottle sits at the edge of the mat. Shot at 35mm with shallow depth of field, in warm honey tones with soft brown shadows. The mood is calm, grounded and quietly hopeful.
supplements

যোগা + অস্টাক্স্যানথিনের মাধ্যমে ডিপ্রেশন স্কোরে ৪৫% হ্রাস, আলাদাভাবে কম প্রভাব

BY NOVA CHEN ·

একটি ১২‑সপ্তাহের র‍্যান্ডমাইজড ট্রায়াল ১০০জন পোস্টমেনোপজাল নারীর মধ্যে দেখা গেছে, হাথা যোগা এবং দৈনিক ১২ মিগ্রা অস্টাক্স্যানথিনের সমন্বয়ে ডিপ্রেশন স্কোর (HAM‑D) ৪৫.১% কমেছে। আলাদাভাবে যোগা মাত্র ২৮.৫% এবং অস্টাক্স্যানথিন মাত্র ১০.৯% হ্রাস ঘটিয়েছে। এই সমন্বয় মেনোপজের লক্ষণ, অ্যান্টিঅক্সিড্যান্ট এনজাইমের কার্যকলাপ এবং NRF1 প্রকাশেও উন্নতি ঘটিয়েছে, যেখানে SIRT1 ও PGC‑1α উভয়ই যোগা গ্রুপে বাড়ে। তবে গবেষণাটি একক কেন্দ্রের ছোট একটি গবেষণা, তাই ফলাফলকে সতর্কতার সঙ্গে বিবেচনা করা দরকার।

Approach: Macro science. Palette: D, bold color field.

Extreme close-up microscopy-style photograph of a stained rat skeletal muscle cross-section, shot straight down through the microscope objective. Polygonal muscle fibers fill the frame in saturated magenta and pink eosin tones. A cluster of fibers on the left is neatly packed and uniform. On the right, the tissue is disrupted, with swollen gaps and thin, fibrous collagen strands in pale violet threading between damaged cells. A few tiny electric green fluorescent specks sit along one fiber edge as a subtle accent. Lighting is bright, even transmitted light with crisp focus at the center and soft falloff at the edges. The mood is analytical and tense, a rescue only partly complete. No text, no labels.
peptides

BPC‑157 র্যাটের পেশীকে রক্তপ্রবাহের আঘাত থেকে রক্ষা করেছে—সীমাবদ্ধতা সহ

BY NOVA CHEN ·

একটি পেশীতে রক্তপ্রবাহ বন্ধ হয়ে পুনরায় চালু করলে রিকম্বের নিজস্ব প্রক্রিয়াই বড় ক্ষতি করতে পারে। সাম্প্রতিক র্যাট গবেষণায় দেখা গেছে, ইস্কেমিয়া শেষের দিকে দেওয়া BPC‑157 অক্সিডেটিভ চাপ, অ্যাপোপটোসিস সংকেত এবং প্রদাহ কমিয়ে VEGF‑এর অংশিক পুনরুদ্ধার ঘটিয়েছে। টিস্যু স্টেইনিংতে পেশীর গঠন উন্নত এবং কলাজেন জমা কম দেখা গেছে। তবে গবেষণায় মাত্র ৬টি র্যাট প্রতি গ্রুপ, একটিমাত্র ২০ µg/kg ইন্ট্রাপেরিটোনিয়াল ডোজ এবং মাত্র ২ ঘণ্টার রিইপারফিউশন ব্যবহার করা হয়েছে। BPC‑157 কোনো অনুমোদিত ওষুধ নয় এবং এটি কেবল প্রাণীভিত্তিক গবেষণা, যা মানব ব্যবহারকে সমর্থন করে না।

Approach: conceptual metaphor. Palette: bold color field.

A single oversized brass balance scale sits on a saturated tomato-red seamless backdrop, photographed at a low three-quarter angle. One pan holds a small, glowing ember-orange coal that is cooling and dimming to grey ash at its edges, standing for inflammation. The other pan holds a tightly coiled, freshly cut green plant sprout with a tiny electric green (#00e676) tip, standing for repair and growth. The scale tips slightly toward the ember, leaving the viewer unsure which side is better. Hard but clean studio key light from upper left casts a crisp, graphic shadow across the red surface. Brass shows real fingerprints and fine scratches, and the ash has a visible powdery texture. The mood is tense, thoughtful and questioning, with the whole image shot at shallow depth of field and the fulcrum in sharp focus. No text, no markings on the scale.
supplements

NMN ট্রেনিং পরে পেশীর প্রদাহ কমায় — তবে কোন মূল্যে?

BY NOVA CHEN ·

NMN‑কে সেলুলার‑শক্তি বাড়ানোর সাপ্লিমেন্ট হিসেবে প্রচার করা হয়, তবে সাম্প্রতিক পেশী‑বায়োপসি গবেষণায় অপ্রত্যাশিত একটি ট্রেড‑অফ দেখা গেছে। রক্ত‑প্রবাহ বাধা (BFR) দিয়ে করা তীব্র প্রশিক্ষণের পরে দিনে ১,২০০ মিগ্রা NMN প্রদাহজনক সিগন্যাল যেমন TNF‑α এবং IL‑10 দমন করে, তবে মাইটোকন্ড্রিয়ার ১৭১ % বৃদ্ধিকে সম্পূর্ণভাবে নষ্ট করে। গবেষণাটি মাত্র ১১ জন অপ্রশিক্ষিত তরুণ পুরুষে করা, তাই এটি সর্বজনীন কোনো সিদ্ধান্তে পৌঁছাতে পারে না, তবে প্রশ্ন থাকে যে ওয়ার্কআউটের পর কম প্রদাহ সবসময়ই ভাল কি না।

**Approach: Lab in action. Palette: D, bold color field (teal).**

Overhead three-quarter angle on a gloved hand holding a small insulin-style syringe over a tray of mouse-muscle tissue samples. The nitrile glove is bright white, and the backdrop is a saturated teal lab bench surface with a soft sheen. Tiny clear microtubes sit in a rack, and a few contain a faint amber liquid. One thin electric green cap on a tube is the only green accent. The lighting is bright, even studio-like lab light with crisp, soft-edged shadows and a gentle highlight on the syringe barrel and a single hanging droplet at the needle tip. The depth of field is shallow, so the background tubes blur into teal. The mood is precise, focused and quietly hopeful, with no readable text or labels anywhere.
peptides

একটি ইনজেকশনের মাধ্যমে এক ঘণ্টায় বয়স্ক ইঁদুরের পেশীর মাইটোকন্ড্রিয়া যেন তরুণের মতো হয়ে যায়

BY HELIX WARD ·

একটি মাত্র SS‑31 (এল্যামিপ্রেটাইড) ইনজেকশন বয়স্ক ইঁদুরের পেশীর মাইটোকন্ড্রিয়ার শক্তি উৎপাদনকে এক ঘন্টার মধ্যে যুবকের স্তরে ফিরিয়ে দেয়। এই ফলাফল ২০১৩ সালের এক ইঁদুর গবেষণার ভিত্তিতে, মানব পরীক্ষার নয়। তরুণ পেশীতে পেপটাইডের কোনো লক্ষণীয় প্রভাব দেখা যায়নি, আর আট দিন ধারাবাহিক চিকিৎসা বয়স্ক প্রাণীর সহনশীলতা বাড়িয়ে দিয়েছে। মানুষের ক্ষেত্রে, এল্যামিপ্রেটাইড বারথ‑সিন্ড্রোমের জন্য FDA‑এর ত্বরান্বিত অনুমোদন পেয়েছে, কিন্তু MMPOWER‑3 ট্রায়াল মাইটোকন্ড্রিয়াল মায়োপ্যাথিতে ব্যর্থ হয়েছে। গ্রে‑মার্কেটের “রিসার্চ পেপটাইড” কেনা এখনই ঝুঁকিপূর্ণ।

This page is available in